Yujiro Hata - Aug 19, 2021 Form 4 Insider Report for ENANTA PHARMACEUTICALS INC (ENTA)

Role
Director
Signature
/s/ Nathaniel S. Gardiner as attorney-in-fact
Stock symbol
ENTA
Transactions as of
Aug 19, 2021
Transactions value $
$0
Form type
4
Date filed
8/23/2021, 04:44 PM
Previous filing
Jun 25, 2021
Next filing
Mar 2, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ENTA Stock Option (right to buy) Award $0 +13.1K $0.00 13.1K Aug 19, 2021 Common Stock 13.1K $48.58 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Such option will become exercisable monthly in substantially equal installments over three years, beginning from the date of grant (August 19, 2021).